Loading provider…
Loading provider…
Hematology & Oncology Physician in Oklahoma City, OK
NPI: 1679542963Primary Practice Location
O U MEDICAL CENTER
1200 N Childrens Ave, Oklahoma City, OK
Primary Employer
OU Health Partners
ouhealth.com
HQ Phone
Get MD George's Phone Numberphone_androidMobile
Get MD George's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOK State Medical License
Incidence and risk factors for graft failure in the modern era of cord blood transplantation.
DMSO induced myocardial infarction during allogeneic cryopreserved bone marrow transplant.
Authors: Amrita Krishnan, Christopher Bredeson, Christopher Dandoy, Mark Juckett
Journal: Biol Blood Marrow Transplant
Publication Date: 2018-01-31
Lead Sponsor: PrECOG, LLC.
Collaborators: Astellas Pharma Inc
Intervention / Treatment: DRUG: Midostaurin, DRUG: Cytarabine, DRUG: Daunorubicin, DRUG: Gilteritinib
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Nivolumab, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, BIOLOGICAL: Pegfilgrastim, OTHER: Quality-of-Life Assessment, RADIATION: Radiation Therapy, DRUG: Dacarbazine, DRUG: Brentuximab Vedotin, PROCEDURE: Computed Tomography, BIOLOGICAL: Filgrastim, DRUG: Vinblastine Sulfate, DRUG: Doxorubicin Hydrochloride
Lead Sponsor: Center for International Blood and Marrow Transplant Research
Collaborators: National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI), Medical College of Wisconsin, Blood and Marrow Transplant Clinical Trials Network, National Marrow Donor Program
Intervention / Treatment: OTHER: Donor Search Prognosis Score